MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2019 International Congress

    Successful altruistic living kidney donation in a patient with Huntington’s disease

    C. Cooper, S. Chen, B. Bernard, J. Goldman (Chicago, IL, USA)

    Objective: To report a case of a Huntington’s Disease (HD) patient who underwent living kidney donation and examine the decision-making process and ethical considerations of…
  • 2019 International Congress

    A case report of two siblings Aicardi-Goutières Syndrome type 2

    C. Fujiwara Murakami, E. Nakagawa, A. Meira, F. Germiniani, E. Pereira, H. Ghizoni Teive (Curitiba, Brazil)

    Objective: To report two sisters with late diagnosis of Aicardi-Goutières Syndrome 2. Background: Aicardi-Goutières Syndrome (AGS) is a rare encephalopathy characterized by basal ganglia calcification,…
  • 2019 International Congress

    Serum mucosal chemokine levels in patients with Parkinson disease.

    S. Haji, W. Sako, N. Murakami, Y. Osaki, Y. Izumi (Tokushima, Japan)

    Objective: To investigate the relationship between mucosal chemokines including CXCL14 and CCL28) and impairment in motor/non-motor function among patients with Parkinson’s disease. Background: Parkinson disease…
  • 2019 International Congress

    APOmorphine infusion and aMYLoid deposition in Parkinson’s disease (APOMYL): preliminary clinical and amyloid imaging data

    D. van Wamelen, M. Politis, D. Aarsland, P. Odin, T. van Laar, T. Henriksen, B. Corcoran, G. Vivian, H. Wilson, M. Parry, A. Sauerbier, N. Mulholland, K. Chaudhuri (London, United Kingdom)

    Objective: To explore the potential effects of chronic Apomorphine infusion treatment on reducing brain Amyloid-b (Aβ) deposition in Parkinson’s disease (PD). Background: A majority of…
  • 2019 International Congress

    Cognitive and psychiatric course in the initial lustrum of Parkinson disease: the glass is half full

    D. Weintraub, C. Caspell-Garcia, H. Cho, T. Simuni, A. Siderowf, C. Coffey, D. Aarsland, R. Alcalay, L. Chahine, J. Eberling, A. Espay, J. Hamilton, J. Leverenz, I. Litvan, I. Richard, L. Rosenthal, M. York (Philadelphia, PA, USA)

    Objective: To describe the cognitive-psychiatric course in the first 5 years of diagnosed Parkinson disease (PD). Background: Although common, little is known about the differential…
  • 2019 International Congress

    Clinical and neuroimaging heterogeneity of dementia with Lewy bodies

    A. Chimagomedova, E. Vasenina, O. Levin (Moscow, Russian Federation)

    Objective: To study clinical and neuroimaging features of dementia with Lewy bodies (DLB) for optimal management and prognosis of the disease. Background: Appropriate diagnosis of DLB…
  • 2019 International Congress

    Validation of the Seoul-instrumental activity daily living in the detection of dementia in Parkinson disease

    SJ. Kim (Busan, Republic of Korea)

    Objective: The Seoul-instrumental activity of daily living (S-iADL) scale is well known to the tool for instrumental activities of Korean elders. However, the cutoff point…
  • 2019 International Congress

    Pisa syndrome in Parkinson’s disease: a study on the neuropsychological profile.

    E. Montanaro, CA. Artusi, S. Tuttobene, A. Romagnolo, M. Zibetti, L. Lopiano (Torino, Italy)

    Objective: To evaluate whether Pisa syndrome (PS) in Parkinson’s disease (PD) is associated with a specific profile of cognitive impairment. Background: PS is a complex…
  • 2019 International Congress

    Cognitive impairment in Parkinson’s Disease: A cross-sectional association study

    A. Simon, C. Rodriguez-Blazquez, MJ. Forjaz, P. Martinez-Martin (Madrid, Spain)

    Objective: To characterize the presence and clinical presentation of PD-MCI and PDD in patients with idiopathic PD, examining motor and non-motor features and determining factors…
  • 2019 International Congress

    Effect of global cognitive score on motor and quality of life outcomes after deep brain stimulation in patients with Parkinson’s disease or essential tremor

    E. Staikova, D. Loring, M. Delong, S. Triche, C. Buetefisch, C. Esper, T. Wichmann, L. Scorr, L. Higginbotham, P. Aia, S. Factor, S. Miocinovic (Atlanta, GA, USA)

    Objective: To determine if preoperative global cognitive score, Mattis Dementia Rating Scale 2nd Edition (DRS-2), predicts motor and quality of life (QoL) outcomes in patients…
  • « Previous Page
  • 1
  • …
  • 91
  • 92
  • 93
  • 94
  • 95
  • …
  • 141
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley